Skip to content
Search

Latest Stories

MHRA campaign to raise Yellow Card Scheme awareness

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a week-long social media campaign to raise awareness about the importance of reporting suspected side effects through the Yellow Card Scheme.

The campaign will focus on polypharmacy, which could increase the likelihood of a patient having side effects, medication errors, as well as the risk of interactions between medicines and with foods or herbal products.


The MHRA is encouraging healthcare professionals to review their patients’ medication intake, especially when prescribing, dispensing and administrating multiple medicines and asked to report suspected side effects to the Yellow Card Scheme.

Mick Foy, MHRA’s Head of Pharmacovigilance Strategy, said: “Protecting patients is our topmost priority. Patients, their carers, and healthcare professionals are asked to report suspected side effects on a Yellow Card to the MHRA online or via the app. Reporting helps to improve the safety of medicines for all patients and can result in better tailored prescribing or administrative advice and information about monitoring, which can help improve adherence to treatment, and ultimately improves patient safety.”

Studies show that one-third of people over 75 years old take at least six medicines and over a million people take eight or more medicines daily. Polypharmacy is common in older people but anyone who routinely uses multiple medicines at the same time can be affected.

More For You

ABPI criticises proposed chances to payment rate for newer branded medicines

DHSC launches an open consultation seeking feedback on the proposed changes to the Statutory Scheme payment rate

Getty Images

Rising payment rate for branded medicines exposes ‘fundamentally broken’ UK market – ABPI

The Association of the British Pharmaceutical Industry (ABPI) has criticised the government’s proposed changes to the Statutory Scheme payment rate for newer branded medicines, warning that it reflects a “fundamentally broken” UK medicines market.

The ‘payment rate’ refers to the amount of revenue pharmaceutical companies must return to the government on their sales of branded medicines to the NHS—an additional charge on top of standard taxes.

Keep ReadingShow less
Man jailed for robbing pharmacy at knifepoint

Daniel Bennett threatened to harm staff unless medication was handed over.

Man jailed for robbing pharmacy at knifepoint

A man who robbed a pharmacy in Winterbourne last year at knifepoint has been sentenced to prison.

Daniel Bennett, 41 of Wedmore Vale in Bedminster, was jailed for six years and nine months, with an extended three-year licence period, after pleading guilty to robbery and possession of a bladed article.

Keep ReadingShow less
NHS England reform: Community pharmacy is missing from the conversation, says Numark

Harry McQuillan, chairman of Numark

Abolition of NHS England – an opportunity for change, says Numark

Numark has welcomed prime minister Keir Starmer’s decision to abolish NHS England but emphasised the need to ensure community pharmacy is not overlooked in the restructuring.

Harry McQuillan, chairman of Numark, described the announcement as “a bold move” that signals a desire to put the NHS "back at the heart of government where it belongs.”

Keep ReadingShow less
national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less